| Product NDC: | 25021-110 |
| Proprietary Name: | Cefoxitin |
| Non Proprietary Name: | cefoxitin sodium |
| Active Ingredient(s): | 2 g/1 & nbsp; cefoxitin sodium |
| Administration Route(s): | INTRAVENOUS |
| Dosage Form(s): | POWDER |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 25021-110 |
| Labeler Name: | Sagent Pharmaceuticals |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA065414 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20091105 |
| Package NDC: | 25021-110-20 |
| Package Description: | 10 VIAL in 1 CARTON (25021-110-20) > 1 POWDER in 1 VIAL |
| NDC Code | 25021-110-20 |
| Proprietary Name | Cefoxitin |
| Package Description | 10 VIAL in 1 CARTON (25021-110-20) > 1 POWDER in 1 VIAL |
| Product NDC | 25021-110 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | cefoxitin sodium |
| Dosage Form Name | POWDER |
| Route Name | INTRAVENOUS |
| Start Marketing Date | 20091105 |
| Marketing Category Name | ANDA |
| Labeler Name | Sagent Pharmaceuticals |
| Substance Name | CEFOXITIN SODIUM |
| Strength Number | 2 |
| Strength Unit | g/1 |
| Pharmaceutical Classes | Cephalosporin Antibacterial [EPC],Cephalosporins [Chemical/Ingredient] |